Jin Yang Pharmaceutical Co. Ltd Cash Flow Quality Index
Jin Yang Pharmaceutical Co. Ltd cash flow quality index. Jin Yang Pharmaceutical Co. Ltd (007370) has a Cash Flow Quality Index of 3.66x as of June 2026. Operating cash flow of ₩8.05 Billion exceeds net income of ₩2.20 Billion, indicating high earnings quality where cash backs reported profits. See Jin Yang Pharmaceutical Co. Ltd (007370) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Jin Yang Pharmaceutical Co. Ltd (2014–2025)
Cash flow quality index of Jin Yang Pharmaceutical Co. Ltd from 2014 to 2025. Historical Cash Flow Quality Index for Jin Yang Pharmaceutical Co. Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 007370 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Jin Yang Pharmaceutical Co. Ltd Cash Flow Quality Index by Year (2014–2025)
Jin Yang Pharmaceutical Co. Ltd cash flow quality index by year from 2014 to 2025. Year-by-year earnings quality comparison for Jin Yang Pharmaceutical Co. Ltd. For the full cash flow conversion analysis, see Jin Yang Pharmaceutical Co. Ltd (007370) cash flow conversion.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | ₩1.46 Billion | ₩22.29 Billion | ▼ -84.7% |
| 2024 | 0.43x | ₩12.79 Billion | ₩29.69 Billion | ▼ -36.1% |
| 2023 | 0.67x | ₩8.53 Billion | ₩12.66 Billion | ▲ +11.4% |
| 2022 | 0.61x | ₩7.45 Billion | ₩12.31 Billion | ▲ +192.9% |
| 2021 | 0.21x | ₩1.97 Billion | ₩9.54 Billion | ▼ -87.8% |
| 2020 | 1.70x | ₩6.24 Billion | ₩3.68 Billion | ▼ -61.2% |
| 2019 | 4.38x | ₩7.21 Billion | ₩1.65 Billion | ▲ +285.9% |
| 2018 | 1.13x | ₩1.06 Billion | ₩933.15 Million | ▲ +247.7% |
| 2014 | -0.77x | ₩-3.08 Billion | ₩4.01 Billion | — |